IRESS Acquired Market Data Provider, QuantHouse

On 31 May 2019, Fintech Company, IRESS Limited (ASX: IRE) announced that it had acquired an established international market data provider, QuantHouse. Also, IRE believes that the acquisition of QuantHouse would be strategically aligned and highly complementary to IRESS’ business. Furthermore, the acquisition had been completed on 31 May 2019 through simultaneous signing, as reported.

The announcement read that the total purchase price would be up to €38.9 million (on a debt and cash free basis) along with a condition regarding earnout performance criteria through to the end of 2021, which is a material portion of the total purchase price.

IRESS’ Overview (Source: Company’s Investor Presentation, April 2019)

According to the announcement, QuantHouse is an international provider of market data services and trading infrastructure with a focus on Europe, North America and Asia, and it is providing over 145 data feeds to clients from exchanges and other data providers.

Andrew Walsh, CEO of IRESS, expressed the similarities in both the companies related to the strategy and future business. The acquisition would provide an additional international exposure to IRESS coupled with data to achieve cost synergies and scale. He also said that the acquisition would improve the client base globally and provide real-time access to further services coupled with tapping demand for data beyond desktops.

Additionally, he mentioned that QuantHouse would report a minor loss in 2019 and expects business to become EPS accretive by 2020 on the back of the greater scale and strategic advantage; meanwhile, the focus of IRE remains in achieving efficiency and revenue growth through the combined strength of both entities.

What’s next?


Reportedly, Mr Pierre Feligioni is the co-founder and CEO of QuantHouse and the person concerned with divesting his stake in the company. Also, he would continue to work in his capacity for QuantHouse within IRESS, and all the senior management, employees would be a core part of IRESS.


As reported, the total purchase price of acquisition would be €38.9 million (on a debt and cash free basis), and a material portion of the consideration would depend on earnout performance criteria through to the end of 2021. Also, the potential purchase price depicts less than 2x reported 2018 revenue of €21.2 million, and it expects to report a loss in 2019.

The acquisition is expected to be EPS accretive starting from 2020; however, once fully integrated with IRESS’ business expected synergies would be consequential to the EBITDA multiple of less than 10x, reportedly.

As per the release, the cost of acquisition is expected at approximately €1.5 million and integration costs of approximately €0.4 million, most of the cost would be reported as Non-Operating Items in 2019. Lastly, the acquisition would be funded by existing facilities, and post the transaction, the IRE remains conservatively geared with a leverage ratio of 1.5x Segment Profit.

By the end of the trading session, on 3 June 2019, IRE stock was at A$13.255, down by 2.608% from its previous close, with a market capitalisation of ~A$2.38 billion. The Year-to-date return of the stock is +26.02% along with three-month performance +11.28%.

Also Read: IRESS Limited’s Stock Arrowed Up On Robust Financial Results For Fiscal 2018.

Also Read: IRESS Announces ASX’s Exit From Its Shareholding.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report